The effects of a Th1-cell-associated cytokine (interferon-␥ [IFN-␥ ]) and Th2-cell-associated cytokines (interleukin [IL]-4, IL-10, and IL-13) on prostaglandin (PG) production by human alveolar macrophages (AM) were examined in terms of four parameters: PGE 2 synthesis, cyclooxygenase (COX) activity, and the protein and mRNA of two COX isozymes (COX-1 and COX-2). Lipopolysaccharide (LPS)-stimulated PGE 2 synthesis and COX activity were suppressed significantly by IL-4, but were not affected significantly by IL-10, IL-13, or IFN-␥ . The LPS-dependent increase in COX activity in AM was attributable to COX-2 because it was inhibited by NS-398 (a COX-2-specific inhibitor). Western and Northern blot analyses revealed that the LPS-induced increases in COX-2 protein and mRNA were attenuated by IL-4 but hardly affected by IL-10, IL-13 or IFN-␥ . In contrast, COX-1 protein and mRNA were hardly detected in any of the AM preparations. In AM and monocytes from the same individuals, LPS induced the synthesis of large amounts of PGE 2 and COX-2 mRNA in AM, and of lesser amounts in monocytes. IL-4, IL-10, and IL-13 significantly suppressed LPS-dependent PGE 2 synthesis and COX-2 mRNA induction in monocytes, whereas only IL-4 significantly suppressed them in AM. Furthermore, 15-lipoxygenase mRNA was detectable only in monocytes incubated with LPS plus IL-4. These results suggest that IL-4 is a potent regulator of PG production in AM, and that regulation of the arachidonic-acid (AA) metabolic pathway in cells of monocyte-macrophage lineage by Th2-cell-associated cytokines depends on the stage of cell differentiation. Endo, T., F. Ogushi, T. Kawano, and S. Sone. 1998. Comparison of the regulations by Th2-type cytokines of the arachidonic-acid metabolic pathway in human alveolar macrophages and monocytes. Am. J. Respir. Cell Mol. Biol. 19:300-307.
Prostaglandin (PG) endoperoxide synthase is the rate-limiting enzyme for the production of PGs and thromboxanes from arachidonic acid (AA). The enzyme is bifunctional, with both fatty-acid cyclooxygenase (COX) activity (producing PGG 2 from AA) and PG hydroperoxidase activity (converting PGG 2 to H 2 ) (1). It is now evident that in many cells there are two forms of COX: a constitutive enzyme, designated COX-1, which is important in physiologic functions, and an inducible enzyme, COX-2, which is upregulated in inflammatory cells such as monocytes, macrophages, vascular endothelial cells, and fibroblasts (2) (3) (4) (5) (6) (7) (8) . Therefore, COX-2 is believed to play an important role in the production of PGs at sites of inflammation. For example, COX-2 induction in alveolar macrophages (AM) is thought to be potentially very important in relation to inflammation and pathophysiologic states mediated by PGs, including septic shock and the adult respiratory distress syndrome (ARDS) (9) .
15-Lipoxygenase converts AA to 15-(S)-hydroxyeicosatetraenoic acid (15-[S]-HETE) and lipoxin A 4 , which have been proposed as anti-inflammatory molecules because of their capacities to suppress leukocyte chemotaxis, adherence, and activation, and to antagonize proinflammatory leukotrienes (10) (11) (12) (13) . CD4 ϩ T cells are classified into two subsets, Th1 and Th2 cells, according to the pattern of cytokines they produce. Typically, Th1 cells produce interleukin (IL)-2 and interferon-␥ (IFN-␥ ), whereas Th2 cells secrete IL-4, IL-5, IL-6, IL-10, and IL-13. These Th1-and Th2-cell-associated cytokines have different functions not only in immune but also in inflammatory responses. IFN-␥ primes human monocyte-macrophages to secondary stimuli (e.g., lipopolysaccharide [LPS] ) to produce proinflammatory cytokines (IL-1 and tumor necrosis factor [TNF] ), enhancing the inflammatory response (14, 15) . In contrast, IL-4, IL-10, and IL-13 suppress the production of proinflammatory cytokines such as IL-1 ␣ , IL-1 ␤ , IL-6, IL-8, TNF-␣ , granulocyte colonystimulating factor (G-CSF), and macrophage inflammatory protein 1 ␣ (MIP-1 ␣ ), and increase the production of IL-1 receptor antagonist (IL-1ra) by human monocytes and macrophages (16) (17) (18) (19) (20) (21) (22) (23) . There are recent reports that IL-4, IL-10, and IL-13 downregulate COX-2 expression and PG production in human monocytes (24) (25) (26) , and that IL-4 and IL-13 upregulate 15-lipoxygenase expression in human monocytes (27) . These findings suggest that IL-4, IL-10, and IL-13 are anti-inflammatory agents.
We have reported that IL-4, IL-10, and IL-13 downregulate COX-2 expression and PG production, whereas IFN-␥ does not affect them in human monocytes (26) . Since AM are thought to play an important role in several pathophysiologic events in the alveolar space by producing PG, we thought it necessary to clarify the regulatory mechanism of PG production in AM. Little is known about the regulatory effects of Th1-and Th2-cell-associated cytokines on the expression of COX and on PG production in AM. In addition, there is little information on differences in the AA metabolic pathways in AM and monocytes. Therefore, in this study we compared the regulatory effects of Th2-cell-associated cytokines on COX-2 and 15-lipoxygenase in AM and monocytes derived from the same individuals.
Materials and Methods

Reagents
Fetal calf serum (FCS) and RPMI 1640 were purchased from GIBCO BRL (Gaithersburg, MD) and Nissui Chemical Co. (Tokyo, Japan), respectively. RPMI 1640 supplemented with FCS (10%), glutamine (1 mM), and gentamicin (50 g/ml) was used in all experiments. Recombinant human IL-4 (specific activity: 10 6 U/mg of protein) and recombinant human IFN-␥ (specific activity: 5.36 ϫ 10 6 U/ mg of protein) were kindly provided by Ono Pharmaceutical Co. (Osaka, Japan) and Nippon Roche (Tokyo, Japan), respectively. Recombinant human IL-10 (specific activity: 10 7 U/mg of protein) and recombinant human IL-13 (specific activity: 1.62 ϫ 10 6 U/mg of protein) were kind gifts from DNAX (Palo Alto, CA). None of these materials contained endotoxins, as evaluated with the Limulus amoebocyte assay (Seikagaku Kogyo Co., Tokyo, Japan). LPS derived from the Escherichia coli 055:B5 strain was purchased from Difco Laboratories (Detroit, MI). (5, 6, 8, 11, 12, 14, H[N])PGE 2 (5.698 TBq/mmol), and unlabeled PGE 2 used in the radioimmunoassay (RIA) were purchased from DuPont/NEN Research Products (Boston, MA) and Funakoshi Co. (Tokyo, Japan), respectively. Anti-PGE 2 antibody, prepared as described previously (28) , was kindly provided by Dr. Shozo Yamamoto, of the Department of Biochemistry of our institution and was used in the RIA. Rabbit polyclonal antibody against human COX-2 and human 15-lipoxygenase complementary DNA (cDNA) probe were purchased from Cayman (Ann Arbor, MI). Mouse monoclonal antibody against human COX-1 (hPES01), prepared as described previously (29) , was also kindly provided by Dr. Shozo Yamamoto. NS-398 was donated by Taisho Pharmaceutical Co. (Saitama, Japan).
Subjects
AM were obtained from healthy volunteers (21 to 35 yr of age). These subjects had no evidence by history or physical examination of lung disease, were nonsmokers, were not taking medication, and had normal chest roentgenograms. All gave written informed consent to participate in the experiments.
Isolation of AM and In Vitro Stimulation
Bronchoalveolar lavage (BAL) was performed as described in detail elsewhere (30) . Briefly, the oral cavity and the upper airway were anesthetized with lidocaine spray, and the tip of an Olympus fiberoptic bronchoscope (Model 1T20; Olympus Co., Tokyo, Japan) was wedged into a segment of the right lung. The lung was washed with 50 ml of sterilized saline (0.9% NaCl) prewarmed to 37 Њ C, and the fluid was gently sucked out with a 50-ml syringe. This process was repeated three times. Subsquently, the same operation was also performed in the left lung. A total of 300 ml of saline was instilled, of which about 65% was recovered. The total number of AM was approximately 2.5 ϫ 10 7 cells ( Ͼ 92% viable as determined by trypan blue dye exclusion). More than 89% of these cells were AM as judged by morphology and staining for nonspecific esterase. The other cells were either small mononuclear cells or neutrophils, which were eliminated during subsequent washing. The cells were suspended in RPMI 1640 medium and were plated in 24-well plastic plates (AM density: 2 ϫ 10 5 cells/well) or 60-mm plastic dishes (AM density: 2 ϫ 10 6 cells/plate). Nonadherent cells ( Ͻ 10%) were removed 1 h after plating by gentle washing. The adherent cells (AM) were then incubated in RPMI 1640 containing 10% FCS supplemented with test compounds.
Isolation of Monocytes and In Vitro Stimulation
Mononuclear cells were separated from leukocyte concentrates obtained from healthy volunteers by density gradient centrifugation in lymphocyte separation medium. Monocytes were then isolated by counterflow centrifugal elutriation with a Beckman JE-5.0 system (Beckman Instruments, Fullerton, CA) as described previously (31) . Usually, the purity of the monocyte fraction was over 95%, as judged by morphologic examination and nonspecific esterase staining, and cell viability was over 98% as assessed by the trypan blue dye exclusion test. Monocytes were suspended in RPMI 1640 containing 10% FCS, and were incubated in 24-well plastic plates (monocyte density: 2 ϫ 10 5 cells/well) or 60-mm plastic dishes (monocyte density: 5 ϫ 10 6 cells/ plate) in medium containing test compounds.
Determination of PGE 2 Synthesis
AM or monocytes were incubated in 24-well plastic plates in medium with a compound to be tested for 24 h. Culture media were then harvested, transferred to polypropylene tubes, and centrifuged at 400 ϫ g for 10 min. The cell-free supernatants were removed and stored at Ϫ 30 Њ C until determination of PGE 2 content by RIA. RIA of PGE 2 was performed as described previously (32) . The sensitivity of the assay for PGE 2 was 70 pg/ml. As previously described (28) , the cross-reactivities of anti-PGE 2 antibodies were as follows: PGE 1 (7.0%), PGF 2 ␣ (4.3%), and 6-keto-PGF 1 ␣ (5.4%), and other arachidonate metabolites (less than 1%). Western Blotting AM were stimulated as for COX assay, and were sonicated as described previously. The cell lysate was mixed with an equal volume of loading buffer (125 mM Tris-HCl, pH 6.8; 4% sodium dodecyl sulfate [SDS]; 2 mg/ml methyl green; 10% glycerol), and subjected to 10% polyacrylamide gel electrophoresis (PAGE) in SDS running buffer (25 mM Tris, pH 8.3; 192 mM glycine; 0.1% SDS). The protein bands were then transferred to an Immobilon-P membrane (Millipore, Bedford, MA) in buffer consisting of 25 mM Tris, pH 8.3; 192 mM glycine; 0.1% SDS; and 20% methanol. The blots were pretreated with 5% goat serum, and were then incubated with rabbit polyclonal antibody raised against human COX-2 as primary antibody, and with biotinylated goat antirabbit IgG as secondary antibody. For Western blot analysis of COX-1 protein, the blots were pretreated with 5% horse serum and then incubated with mouse monoclonal antibody raised against human COX-1 as primary antibody and with biotinylated horse antimouse IgG as secondary antibody. The enzyme protein was visualized by use of the Vectastain avidin-biotin conjugate (ABC) kit (Vector, Burlingame, CA) according to the manufacturer's instructions. PBS containing 0.05% Tween 20 was used as washing buffer throughout the experiment.
COX Assay
Northern Blotting AM or monocytes were stimulated for 24 h with a compound to be tested as described previously. The cells were then scraped off the dishes and homogenized in a mixture of guanidinium isothiocyanate and phenol (ISOGEN; (Nippon Gene, Tokyo, Japan). Total RNA was extracted with chloroform and precipitated with isopropanol. The denatured RNA was subjected to electrophoresis on 1% agarose formaldehyde gel, transferred to a Hybond-N ϩ nylon membrane (Amersham International) in 10 ϫ salinesodium phosphate-EDTA (SSPE) transfer buffer (1 ϫ SSPE: 150 mM NaCl, 10 mM sodium phosphate, 1 mM ethylenediamine tetraacetic acid [EDTA]), and fixed by shaking the membrane in 0.05 N NaOH for 5 min. The membrane was prehybridized at 42 Њ C for 4 h in buffer containing 50% formamide, 0.5% SDS, 5 ϫ SSPE, 5 ϫ Denhardt's mixture (1 ϫ Denhardt's mixture: 0.02% bovine serum albumin [BSA], 0.02% Ficoll, 0.02% polyvinylpyrollidone), and 200 g/ml salmon sperm DNA. The blots were hybridized at 42 Њ C for 12 h with 32 P-labeled probes (10 6 cpm/ml) in buffer containing 50% formamide, 0.5% SDS, 5 ϫ SSPE, 5 ϫ Denhardt's mixture, and 200 g/ml salmon sperm DNA. The blot was washed twice with 0.1 ϫ standard saline citrate (SSC)-0.1% SDS-1 mM EDTA (1 ϫ SSC: 150 mM NaCl, 15 mM sodium citrate) for 5 min at room temperature and then with the same solution for 5 min at 65 Њ C, and were autoradiographed with a Fujix bioimaging analyzer BAS 2000. Stripping for rehybridization was done by washing the membrane in 0.5% SDS for 5 min at 95 Њ C. The probes used were cDNA fragments of human COX-1 and COX-2, which were prepared as described previously (8), and ␤ -actin and cDNA (Wako, Osaka, Japan). These probes were labeled with [ ␣ - 
Statistical Analysis
Results are given as means Ϯ SD. Significant differences were calculated through one-way analysis of variance (ANOVA), with post hoc comparisons according to Bonferroni's method. A value of P Ͻ 0.05 was considered significant.
Results
Effects of Th1-and Th2-cell-associated Cytokines on PGE 2 Release
The effects of Th1-and Th2-cell-associated cytokines on PGE 2 release by AM into the culture medium were examined. As shown in Figure 1 , LPS-stimulated PGE 2 production was significantly inhibited by IL-4 ( P Ͻ 0.05), but was not affected significantly by IL-10, IL-13, or IFN-␥ . The PGE 2 content of the culture medium of cells incubated in medium alone or with each cytokine alone was below the Figure 1 . Effects of IL-4, IL-10, IL-13, and IFN-␥ on PGE 2 synthesis by AM. AM were incubated with 100 U/ml IL-4, 100 U/ml IL-10, 100 ng/ml IL-13, or 100 U/ml IFN-␥ for 24 h in the presence or absence of 1 g/ml LPS, and the amount of PGE 2 released into the culture medium was determined by RIA. Values are means Ϯ SD of data for cells from three volunteers. detection limit. AM were preincubated with IL-10 or IL-13 for 2 h and then washed and incubated with LPS for 24 h. Again, PGE 2 production was not significantly affected by IL-10 or IL-13 (data not shown).
Effects of Th1-and Th2-cell-associated Cytokines on COX Activity After determination of PGE 2 release from LPS-stimulated or unstimulated AM incubated with each cytokine, the COX activities of the cell lysates were measured with [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]AA as substrate. Previous experiments showed a time-dependent increase of COX activity in AM stimulated with 1 g/ ml LPS (data not shown). To determine whether the COX activity observed in the lysate of LPS-stimulated AM was derived from COX-2, we examined the effect of NS-398, a selective inhibitor of COX-2 (33). NS-398 inhibited the LPS-stimulated COX activity dose-dependently, suggesting that most of the COX activity in the LPS-stimulated AM was derived from COX-2 ( Figure 2 ). As expected, indomethacin, a nonspecific COX inhibitor, also inhibited the COX activity dose-dependently. We also investigated the effects of Th1-and Th2-cell-associated cytokines on COX activity. IL-4 significantly inhibited the LPS-induced increase in COX activity (P Ͻ 0.05) (Figure 3 ), suggesting that it inhibited LPS-dependent COX-2 induction in AM. The activity was not significantly affected by IL-10, IL-13, or IFN-␥ (Figure 3) .
Effects of Th1-and Th2-cell-associated Cytokines on COX-2 Protein Levels
To determine whether the suppression of COX activity by IL-4 was due to a reduction in the amount of COX-2 protein, we performed Western blot analysis using a primary antibody against COX-2. As shown in Figure 4 , a 71-kD protein band corresponding to COX-2 was evident in the cell lysate from LPS-stimulated AM. COX-2 was not detectable in the cell lysate of control AM or AM treated with IL-4, IL-10, IL-13, or IFN-␥ alone. The LPS-induced increase in COX-2 protein was inhibited by the addition of IL-4 but not affected appreciably by IL-10, IL-13, or IFN-␥. A 58-kD protein band was also detected, and appeared to represent nonspecifically bound antibody because it was detectable in all AM lysates. In contrast, no protein band corresponding to COX-1 was detectable in the cell lysates (13 g of protein) of AM incubated with or without LPS or in the presence or absence of IL-4, IL-10, IL-13, or IFN-␥ (data not shown). However, the specificity of hPES01 for COX-1 protein was verified by detecting a 71-kD protein band corresponding to COX-1 in a microsome fraction obtained from human platelets and in IMR-90 cells (human Effects of IL-4, IL-10, IL-13, and IFN-␥ on COX activity of AM. AM were incubated with 100 U/ml IL-4, 100 U/ml IL-10, 100 ng/ml IL-13, or 100 U/ml IFN-␥ for 24 h in the presence or absence of 1 g/ml LPS. COX activity was determined after sonication of the cells, using [1- 14 C]AA as substrate, and was expressed as nanomoles of converted [1- 14 C]AA per milligram of protein in 2 min. Values are means Ϯ SD of data for cells from three volunteers. Figure 4 . Effects of IL-4, IL-10, IL-13, and IFN-␥ on COX-2 enzyme mass in AM. AM were incubated with 100 U/ml IL-4, 100 U/ml IL-10, 100 ng/ml IL-13, or 100 U/ml IFN-␥ for 24 h in the presence or absence of 1 g/ml LPS. AM lysates (13 g of protein) were subjected to SDS-PAGE. Immunoblotting was performed with polyclonal antibody against human COX-2. Positions of molecular-mass marker proteins are indicated by arrows. embryonic lung fibroblasts) ( Figure 5A ). In addition, COX-1 protein was detected in very large amounts (100 g) of the total protein obtained from resting AM and LPS-stimulated AM ( Figure 5A ). With primary antibody against COX-2, COX-2 protein was detectable in the cell lysate (100 g of protein) of resting AM, and was markedly increased upon stimulation with LPS ( Figure 5B ).
Effects of Th1-and Th2-cell-associated Cytokines on COX-1 and -2 mRNA Levels
We evaluated the effects of Th1-and Th2-cell-associated cytokines on the mRNA levels of the two COX isozymes. Total RNA (3 g) was extracted from AM incubated with or without LPS in the presence or absence of IL-4, IL-10, IL-13, or IFN-␥, and was subjected to Northern blot analysis ( Figure 6 ). COX-2 mRNA was undetectable in resting cells, but was induced dramatically on addition of LPS. This induction was suppressed by IL-4, but scarcely affected by IL-10, IL-13, or IFN-␥. In contrast, with the cDNA for COX-1 as a probe, no band was detected in 3 g of total RNA from any of the AM preparations. However, when a larger amount (30 g) of total RNA obtained from resting AM, LPS-stimulated AM, and IMR-90 cells was subjected to Northern blot analysis for COX-1, a very weak signal of a 3.0-kb band was detected in RNA obtained from resting and LPS-stimulated AM, whereas a larger amount of COX-1 mRNA was detected in RNA from IMR-90 cells (Figure 7) . In addition, a very weak signal of COX-2 mRNA was detected in RNA obtained from resting AM, and was markedly increased after stimulation by LPS (Figure 7) .
Comparison of PGE 2 Production by AM and Monocytes
We found previously that IL-4, IL-10, and IL-13 inhibited LPS-induced PGE 2 production by human monocytes (26) . Therefore, we next compared the PGE 2 production in AM and monocytes, and their regulation by Th2-cell-associated cytokines, using AM and monocytes from the same individuals. As shown in Figure 8 , the PGE 2 content of the culture medium was below the limit of detection when AM or monocytes were incubated in medium alone, but was siginificantly increased by LPS. LPS-induced PGE 2 production by AM was about 6-fold greater than that by monocytes. Furthermore, IL-4, IL-10, and IL-13 significantly Figure 5 . COX-1 and -2 protein levels in resting AM, in LPSstimulated AM, in human platelets, and in IMR-90 cells. AM were incubated for 24 h with or without 1 g/ml LPS. AM lysate (100 g of protein ), human platelet microsome, and IMR-90 cell lysate were subjected to SDS-PAGE. Immunoblots were performed with monoclonal antibody against human COX-1 (hPES01) (A) or with polyclonal antibody against human COX-2 (B). Positions of molecular-mass marker proteins are indicated by arrows. Figure 6 . Effects of IL-4, IL-10, IL-13, and IFN-␥ on COX-1 and -2 mRNA levels in AM. AM were incubated for 24 h with or without LPS (1 g/ml) in the presence of 100 U/ml IL-4 (A), 100 U/ml IL-10 (B), 100 ng/ml IL-13 (C), or 100 U/ml IFN-␥ (D). Total RNA (3 g) was isolated and subjected to Northern blot analysis with cDNA probes complementary to mRNAs of COX-1, COX-2, and ␤-actin for detection of bands. The positions of 28S and 18S ribosomal RNAs (rRNAs) are indicated by arrows.
suppressed LPS-induced PGE 2 production by monocytes (P Ͻ 0.05), but only IL-4 significantly suppressed that by AM (P Ͻ 0.05).
COX-2 and 15-Lipoxygenase mRNA Levels in AM and Monocytes from the Same Individuals
We investigated the COX-2 mRNA levels in the same AM and monocytes as used for evaluation of PGE 2 production. In parallel with PGE 2 production, LPS induced the synthesis of a large amount of COX-2 mRNA in AM and a lesser amount in monocytes, and IL-4, IL-10, and IL-13 significantly suppressed LPS-dependent COX-2 mRNA induction in monocytes, whereas only IL-4 significantly suppressed it in AM (Figure 9 ). 15-Lipoxygenase catalyzes the C-5 hydroperoxidation of fatty acids, resulting in the generation of anti-inflamatory products. Expression of its mRNA was detected only in monocytes incubated with LPS plus IL-4 ( Figure 9 ).
Discussion
AM can produce various COX products, such as thromboxane, PGE 2 , and PGD 2 , among which thromboxane is the major product (34, 35) . However, the increase in PGE 2 production has been shown to correlate, in mass, with newly synthesized COX in LPS-stimulated human AM (35) . Therefore, in this study, we measured PGE 2 production in order to evaluate the regulation of COX-2 activity in LPS-stimulated human AM.
We have reported that Th2-cell-associated cytokines (IL-4, IL-10, and IL-13) suppress PG production by downregulating COX-2 expression in human monocytes (26) . Therefore, we examined whether these cytokines had similar effects on AM. Unexpectedly, of these cytokines, only IL-4 significantly inhibited PG production, COX activity, and COX-2 induction in AM. There are several possible explanations for the difference between the regulations in AM and monocytes. One is a difference in affinity or num- Figure 8 . Effects of IL-4, IL-10, and IL-13 on PGE 2 synthesis by AM and monocytes derived from the same individuals. AM and monocytes were incubated with 100 U/ml IL-4, 100 U/ml IL-10, or 100 ng/ml IL-13 for 24 h in the presence or absence of 1 g/ml LPS, and the amount of PGE 2 released into the culture medium was determined by RIA. Value are means Ϯ SD of data for cells from three volunteers. Figure 9 . Effects of IL-4, IL-10, and IL-13 on COX-2 and 15-lipoxygenase mRNA levels in AM and monocytes derived from the same individuals. AM and monocytes were incubated with 100 U/ ml IL-4, 100 U/ml IL-10, or 100 ng/ml IL-13 for 24 h in the presence or absence of 1 g/ml LPS. Total RNA (10 g) was isolated and subjected to Northern blot analysis with cDNA probes complementary to mRNAs of COX-2, 15-lipoxygenase (15-LOX), and ␤-actin for detection of bands. The positions of 28S and 18S rRNA are indicated by arrows.
ber of Th2-cell-associated cytokine receptors, because we found that suppressive effects of Th2-cell-associated cytokines on IL-1␤ and TNF-␣ production in monocytes were significantly greater than those in AM (data not shown). Another explanation is a difference in the signaltransduction pathway for COX-2 induction. Contrary responses are reported for AM and monocytes concerning IFN-␥-and C-reactive-protein-dependent IL-1ra production (36, 37) . Further studies are needed to clarify the mechanisms involved.
Although there are reports that COX-1 mRNA is detectable in AM, the discrepancy between previous results and ours may be due to the sensitivity of the experimental methods or differences in the animal species used. Namely, Lee and colleagues and Chanmugam and associates investigated the expression of COX-1 mRNA using the reverse transcription-polymerase chain reaction (RT-PCR) and ribonuclease (RNase) protection assay, respectively (38, 39) , and found relatively large amounts of COX-1 (40) .
There are reports that PGE 2 may be a cytoprotective and anti-inflammatory prostanoid (41, 42) ; however, LPSstimulated human AM have been shown to produce various prostanoids other than PGE 2 upon induction of COX-2 (35) . At a certain stage of inflammation, these COX-2 products may act as proinflammatory factors, because administration of NS-398 can reduce the inflammatory response in vivo (43) . 15-(S)-HETE inhibits leukotriene B 4 (LTB 4 ) generation by leukocytes (44) , antagonizes neutrophil chemotaxis by LTB 4 (45) , and inhibits leukocyte activation (44, 46) . Lipoxin A 4 attenuates LTB 4 -induced chemotaxis and decreases leukocyte-endothelial-cell adhesion (10, 13) . Because these compounds are produced by 15-lipoxygenation of AA, the inducers of this enzyme are potent anti-inflammatory agents. IL-4 is a leading candidate for such an agent, since it not only downregulates COX-2 but also upregulates 15-lipoxygenase in monocytes stimulated with LPS. Interestingly, Levy and coworkers reported that IL-4 induces 15-lipoxygenase mRNA in AM under spontaneous conditions (47) . Furthermore, Nassar and associates reported that IL-4 and IL-13 induce 15-lipoxygenase mRNA individually in monocytes (27) .
Yano and coworkers reported that IL-4 inhibits LPSinduced expression of COX-2 in human AM (48) . In the present study, we examined the regulatory effects of IL-10, IL-13, and IL-4 on the expression of COX-2 and PG production in AM for the first time, and showed that IL-10 and IL-13 had hardly any affect, whereas IL-4 caused significant suppression of COX-2 and PG production, in accord with Yano and coworkers' observation. In addition, we clearly demonstrated the differential regulation of COX-2 and 15-lipoxygenase in AM and monocytes. We also found that IL-4, IL-10, and IL-13 regulated monocyte chemoattractant protein-1 (MCP-1) production by human peripheral monocytes and AM in different ways (49) . Peripheral blood monocytes, believed to be the primary source of AM, migrate from the blood compartment to become residents of the lung air space (50) (51) (52) . Unlike blood monocytes, AM are always exposed to inhaled environmental agents and must defend the human lung from invasion by these harmful agents. Because an inflammatory response is a defense of the human body, it may be beneficial that inflammatory COX-2 products are more difficult to downregulate, whereas anti-inflammatory 15-lipoxygenase products are more difficult to upregulate in AM than in monocytes.
IL-4 and IL-10 have been reported to exert protective effects in an animal model of acute lung injury in association with a reduction in the neutrophil content of the alveolar space (53) . Our results suggest that these cytokines, and especially IL-4, may suppress the accumulation of neutrophils, consistent with a downregulation of COX-2 products increasing vascular permeability and an upregulation of 15-lipoxygenase products inhibiting neutrophil chemotaxis.
Further study is warranted to clarify the significance of regulation of the AA metabolic pathway in cells of monocyte-macrophage lineage under physiologic or pathologic conditions.
